Scientists probe liver fuel use in fatty liver and diabetes

NCT ID NCT05305287

First seen Jan 11, 2026 · Last updated Apr 24, 2026 · Updated 11 times

Summary

This study looks at how the liver uses energy in people who have both type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). Researchers will measure liver cell activity before and after 16 weeks of treatment with the diabetes drug pioglitazone. The goal is to understand how the drug affects liver metabolism, not to test a new cure or treatment. About 60 adults aged 18-80 with stable diabetes and moderate to severe liver fat will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Texas Diabetes Institute - University Health System

    RECRUITING

    San Antonio, Texas, 78207, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Texas Health Science Center at San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

Conditions

Explore the condition pages connected to this study.